Organigram Holdings Inc
NASDAQ: OGI
$1.25
-$0.04 (-3.1%)
Closing price November 27, 2023
Here are previews of what to expect when three companies release quarterly earnings on Tuesday morning.
Published:
Pot grower Tilray is acquiring a majority position in U.S.-based cannabis retailer MedMen. Is this a portent of more consolidation in the industry?
Published:
Wednesday's announcement of a draft bill that would decriminalize marijuana sent cannabis stocks plummeting. At least some analysts, however, continue to believe in the sector.
Published:
Wednesday's top analyst upgrades and downgrades included AutoZone, Citrix Systems, Coinbase, CSX, Freeport-McMoRan, Intuitive Surgical, Morgan Stanley, Netflix and Oracle.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including NovoCure, Synchrony, Twitter and Yum! Brands.
Published:
With major earnings reports for the March quarter due to begin next week, we end the current earnings season with quarterly reports for a nuts and bolts company and a marijuana producer.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Carvana, DocuSign, F5 Networks and OrganiGram.
Published:
Large marijuana stocks have risen sharply since the U.S. elections early in November. The increase is not based so much on the results as on what could happen next.
Published:
Wednesday's top analyst upgrades and downgrades included Delta Air Lines, Hasbro, Illumina, Lululemon Athletica, Micron Technologies, Nike, Penn National, Shopify, Southwest Airlines, Starbucks and...
Published:
The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Published:
The March 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published:
It’s no secret that the cannabis industry has been smoked so far in 2020. Out of this group, Organigram seems to have fared the best. What comes next?
Published:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks decreased.
Published:
Canadian cannabis grower CannTrust's headwinds include possible delisting from the New York Stock Exchange, overdue financial reports, a class-action lawsuit, black market competition and more.
Published:
Canadian cannabis stocks have performed poorly, in due to the sharp drop in share prices that marijuana stocks suffered last year. Yet, Organigram seemed to be positioned for a better year in fiscal...
Published: